Ari J. Wassner

Ari J. Wassner

Auto-generated profile, based on publicly available information

Ari J. Wassner

Thyroid Center, Boston Children’s Hospital, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2013 in JAMA
Verified
Journal Article
Open access
PDF file
ASAmy J. Starmer
Amy J. Starmer
TSTheodore C. Sectish
Theodore C. Sectish
DSDennis W. Simon
Dennis W. Simon
CKCarol Keohane
Carol Keohane
MMMaireade E. McSweeney
Maireade E. McSweeney
CLChristopher P. Landrigan
Christopher P. Landrigan
Communication errors are a leading cause of sentinel events, unexpected occurrences involving death or serious physical injury, or the risk thereof.1 The Agency for Healthcare Research and Quality (AHRQ) and the Accreditation Council for Graduate Medical Education (ACGME) have identified improving handoffs as a priority in US nationwide efforts to improve patient safety.2,3 The ACGME now requires residency programs to provide formal instruction in handoffs.3 Despite these new requirements and the increasing frequency of handoffs as a result of reductions in resident-physician work hours, many institutions do not have robust procedures for training residents or ensuring high-quality handoffs.4-8

1 August 2013 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
AGAnjuli Gupta
Anjuli Gupta
SLSamantha Ly
Samantha Ly
LCLuciana A. Castroneves
Luciana A. Castroneves
MFMary C. Frates
Mary C. Frates
CBCarol B. Benson
Carol B. Benson
SHStephen A. Huang
Stephen A. Huang
Context: Thyroid cancer is the most common endocrine malignancy, but due to its rare occurrence in the pediatric population, the cancer risk of childhood thyroid nodules is incompletely defined, and optimal management of children with suspected nodules is debated. Objective: The aim was to study the presenting features and cancer risk of sporadic childhood thyroid nodules using a standardized clinical assessment and management plan. Design and Setting: Boston Children's Hospital and Brigham and Women's Hospital collaborated to create a multidisciplinary pediatric thyroid nodule clinic and implement a standardized assessment plan. Upon referral for a suspected nodule, serum TSH was measured and hypothyrotropinemic patients underwent 123I scintigraphy. All others underwent thyroid ultrasonography, and if this confirmed nodule(s) ≥ 1 cm, ultrasound-guided fine-needle aspiration was performed. Medical records were retrospectively reviewed and compared to a control population of 2582 adults evaluated by identical methods. Patients and Results: Of 300 consecutive children referred for the initial evaluation of suspected thyroid nodules from 1997 to 2011, 17 were diagnosed with autonomous nodules by scintigraphy. Neck ultrasonography performed in the remainder revealed that biopsy was unnecessary in over half, either by documenting only sub-centimeter nodules or showing that no nodule was present. A total of 125 children met criteria for thyroid biopsy, which was performed without complication. Their rate of cancer was 22%, significantly higher than the adult rate of 14% (P = .02). Conclusions: Neck ultrasonography and biopsy were key to the evaluation of children with suspected thyroid nodules. Although the relative cancer prevalence of sonographically confirmed nodules ≥ 1 cm is higher in pediatric patients than adults, most children referred for suspected nodules have benign conditions, and efforts to avoid unnecessary surgery in this majority are warranted.

1 March 2015 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
JHJan Halbritter
Jan Halbritter
MBMichelle Baum
Michelle Baum
AHAnn Marie Hynes
Ann Marie Hynes
SRSarah J. Rice
Sarah J. Rice
DTDavid T. Thwaites
David T. Thwaites
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt
Nephrolithiasis is a prevalent condition with a high morbidity. Although dozens of monogenic causes have been identified, the fraction of single-gene disease has not been well studied. To determine the percentage of cases that can be molecularly explained by mutations in 1 of 30 known kidney stone genes, we conducted a high-throughput mutation analysis in a cohort of consecutively recruited patients from typical kidney stone clinics. The cohort comprised 272 genetically unresolved individuals (106 children and 166 adults) from 268 families with nephrolithiasis (n=256) or isolated nephrocalcinosis (n=16). We detected 50 likely causative mutations in 14 of 30 analyzed genes, leading to a molecular diagnosis in 14.9% (40 of 268) of all cases; 20 of 50 detected mutations were novel (40%). The cystinuria gene SLC7A9 (n=19) was most frequently mutated. The percentage of monogenic cases was notably high in both the adult (11.4%) and pediatric cohorts (20.8%). Recessive causes were more frequent among children, whereas dominant disease occurred more abundantly in adults. Our study provides an in-depth analysis of monogenic causes of kidney stone disease. We suggest that knowledge of the molecular cause of nephrolithiasis and nephrocalcinosis may have practical implications and might facilitate personalized treatment.

1 January 2018 in Kidney International
Verified
Journal Article
Closed access
ADAnkana Daga
Ankana Daga
AMAmar J. Majmundar
Amar J. Majmundar
DBDaniela Braun
Daniela Braun
HGHeon Yung Gee
Heon Yung Gee
JLJennifer A. Lawson
Jennifer A. Lawson
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt

1 April 2016 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
DBDaniela Braun
Daniela Braun
JLJennifer Ashley Lawson
Jennifer Ashley Lawson
HGHeon Yung Gee
Heon Yung Gee
JHJan Halbritter
Jan Halbritter
SSShirlee Shril
Shirlee Shril
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt
Background and objectives Nephrolithiasis is a prevalent condition that affects 10%–15% of adults in their lifetime. It is associated with high morbidity due to colicky pain, the necessity for surgical intervention, and sometimes progression to CKD. In recent years, multiple monogenic causes of nephrolithiasis and nephrocalcinosis have been identified. However, the prevalence of each monogenic gene in a pediatric renal stone cohort has not yet been extensively studied. Design, setting, participants, & measurements To determine the percentage of cases that can be explained molecularly by mutations in one of 30 known nephrolithiasis/nephrocalcinosis genes, we conducted a high-throughput exon sequencing analysis in an international cohort of 143 individuals <18 years of age, with nephrolithiasis (n=123) or isolated nephrocalcinosis (n=20). Over 7 months, all eligible individuals at three renal stone clinics in the United States and Europe were approached for study participation. Results We detected likely causative mutations in 14 of 30 analyzed genes, leading to a molecular diagnosis in 16.8% (24 of 143) of affected individuals; 12 of the 27 detected mutations were not previously described as disease causing (44.4%). We observed that in our cohort all individuals with infantile manifestation of nephrolithiasis or nephrocalcinosis had causative mutations in recessive rather than dominant monogenic genes. In individuals who manifested later in life, causative mutations in dominant genes were more frequent. Conclusions We present the first exclusively pediatric cohort examined for monogenic causes of nephrolithiasis/nephrocalcinosis, and suggest that important therapeutic and preventative measures may result from mutational analysis in individuals with early manifestation of nephrolithiasis or nephrocalcinosis.

1 March 2018 in Clinics in Perinatology
Verified
Journal Article
Closed access
AWAri J. Wassner
Ari J. Wassner